|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparison of etanereept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis 显示文摘 | van der Heijde D Klareskog L Rodriguez-Valverde V | 2006 | Arthrtis Rheum2006，54，4： | 1 |
| 2 | Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study显示文摘 | Keystone EC Genovese MC Klareskog L | 2009 | Ann Rheum Dis2009，68，6： | 1 |
| 3 | Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactions显示文摘 | KLARESKOG L McDEVITT H | 1999 | Current Opinionin Immunology1999，11，6： | 1 |
| 4 | CD25brightCIN+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease 显示文摘 | Cao D van Vollenhoven R Klareskog L | 2004 | Arthritis Res Therapy2004，6，： | 1 |
| 5 | Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis 显示文摘 | van der Heijde D Klareskog L Landewe R | 2007 | Arthritis Rheum2007，56，： | 1 |
| 6 | Rheumatoid arthritis显示文摘 | Klareskog L Catrina AI Paget S | 2009 | Lan cet2009，373，9664： | 1 |
| 7 | Compari- son of etanercept and methotrexate,alone and combined,in the treat- ment of rheumatoid arthritis:two-year clinical and radiographic re- sults from the TEMPO study,a double-blind,randomized trial显示文摘 | Der Heijde Dv Klareskog L Rodriguez-Valverde V | 2006 | Arthritis Rheum2006，54，4： | 1 |
| 8 | Cytokine-producing cells in peripheral blood of children with eoeliac disease se- crete cytokines with a type 1 profile显示文摘 | Hansson T Dannaeus A Klareskog L | 1999 | Clin Exp Immunol1999，116，2： | 1 |
| 9 | Socioeconomic status and the risk of developing rheumatoid arthritis:results from the swedish EIRA study显示文摘 | BENGTSSON C NORDMARK B KLARESKOG L | 2005 | Ann Rheum Dis2005，64，： | 1 |
| 10 | Skeletal muscle fibers express major histocompatibility complex class Ⅱ antigens independently of inflammatory infiltrates in inflammatory myopathies显示文摘 | Englund P Lindroos E Nennesmo I Klareskog L Lundberg I E | 2001 | Am J Pathol2001，159，： | 1 |
| 11 | An immunohistochemical analysis of cytokine expression in allergic and irritant contact dermatitis显示文摘 | Ulfgren AK Klareskog L Lindberg M | 2000 | Acta Derm Venereol2000，80，3： | 1 |
| 12 | Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies显示文摘 | Miossec P Verweij CL Klareskog L | 2011 | Ann Rheum Dis2011，70，： | 1 |
| 13 | Risk for malignant lymphoma in ankylosing spondylitis:a nationwide Swedish casecontrol study显示文摘 | Askling J Klareskog L Blomqvist P | 2006 | Ann Rheum Dis2006，65，11： | 1 |
| 14 | Rheumatoid arthritis显示文摘 | Klareskog L Catrina A I Paget S | 2009 | Lancet2009，373，9664： | 1 |
| 15 | A new model for anetiology of rheumatoid arthritis: smoking may trigger HLA - DR ( shared epitope) -restricted immune reactions to auto- antigens nmdified by citrullination 显示文摘 | Klareskog L Stolt P Lundberg K | 2006 | Arthritis Rheum2006，54，1： | 1 |
| 16 | Rheumatoid arthritis 显示文摘 | Klareskog L Catrina AI Paget S | 2009 | Lancet2009，373，9664： | 1 |
| 17 | Therapeutic effect of the combination of etanercept andmethotrexate compared with each treatment alone in patients with rheumatoidarthritis: double-blind randomised controlled trial显示文摘 | Klareskog L van der Heijde D de Jager JP | 2004 | Lancet2004，363，9410： | 1 |
| 18 | Rheumatoid arthritis 显示文摘 | Klareskog L Catrina A I Paget S | 2009 | Lancet2009，373，9664： | 1 |
| 19 | Tumor necrosis factor antagonist mechanisms of action: a comprehensive review 显示文摘 | Tracey D Klareskog L Sasso EH | 2008 | Pharmacol Ther2008，117，2： | 1 |
| 20 | Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis显示文摘 | Klareskog L Malmstrom V Lundberg K | 2011 | Semin Immunol2011，23，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员